摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

bzC(nBzl)pobzA(nBzl)p(NHPh)2 | 73706-14-6

中文名称
——
中文别名
——
英文名称
bzC(nBzl)pobzA(nBzl)p(NHPh)2
英文别名
——
bzC(nBzl)p<sup>o</sup>bzA(nBzl)p(NHPh)2化学式
CAS
73706-14-6
化学式
C65H57ClN12O18P2
mdl
——
分子量
1391.64
InChiKey
NUIXNXWFHAWDLF-IMVXXVDYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

反应信息

  • 作为反应物:
    描述:
    bzC(nBzl)pobzA(nBzl)p(NHPh)2 、 triethylammonium salt of 2'-O-(o-nitrobenzyl)-5'-O-monomethoxytrityl-N-benzoylcytidine 3'-p-chlorophenyl phosphate 在 mesitylenesulfonyl 1,2,4-triazolide 作用下, 以 吡啶 为溶剂, 生成 (MeOTr)bzC(nBzl)pobzC(nBzl)pobzA(nBzl)p(NHPh)2
    参考文献:
    名称:
    转移核糖核酸及其相关化合物的研究。XXXIX。对应于大肠杆菌tRNAfMet 3'端的七聚体和十六碳氢核苷酸的化学合成。
    摘要:
    A heptadecanucleotide corresponding to the 3'-end (bases 61-77) of the tRNAMetf of E.coli was synthesized by the phosphotriester method involving condensation of protected oligonucleotides with chain lengths of 3 to 6. 2'-O-(o-Nitrobenzyl) derivatives of N-acyl-5'-O-monomethoxytrityl nucleosides were used as the starting materials. To protect the 3'-end of the heptadecanucleotide with phosphorodianilidate during the synthesis, protected AACCAp having 3'-phosphorodianilidate was used as the starting nucleotide block. Condensation of protected CCCCGCp or successive condensations of protected CCCp and CGCp gave the protected undecamer in satisfactory yields. The final condensation of the undecamer to protected UCCGGCp yielded the protected heptadecamer, and the product was deprotected to give the 3'-phosphorylated heptadecanucleotide UCCGGCCCCCGAACCAp. A hexadecanucleotide corresponding to the 3'-end of the same tRNAMetf was also synthesized by the phosphotriester method by condensation of the undecamer with protected CCGGCp. The hexadecamer was deblocked and purified by chromatography on ion-exchange and reverse phase supports. This deprotected hexadecanucleotide CCGGCCCCCGCAACCAp (corresponding to bases 62-77) can be joined to the previously synthesized heptamer corresponding to the eukaryotic loop VI sequences to construct a hybrid tRNA.
    DOI:
    10.1248/cpb.29.2799
  • 作为产物:
    描述:
    (MeOTr)bzC(nBzl)pobzA(nBzl)p(NHPh)2 在 溶剂黄146 作用下, 反应 24.0h, 以3.68 g的产率得到bzC(nBzl)pobzA(nBzl)p(NHPh)2
    参考文献:
    名称:
    转移核糖核酸及其相关化合物的研究。XXXIX。对应于大肠杆菌tRNAfMet 3'端的七聚体和十六碳氢核苷酸的化学合成。
    摘要:
    A heptadecanucleotide corresponding to the 3'-end (bases 61-77) of the tRNAMetf of E.coli was synthesized by the phosphotriester method involving condensation of protected oligonucleotides with chain lengths of 3 to 6. 2'-O-(o-Nitrobenzyl) derivatives of N-acyl-5'-O-monomethoxytrityl nucleosides were used as the starting materials. To protect the 3'-end of the heptadecanucleotide with phosphorodianilidate during the synthesis, protected AACCAp having 3'-phosphorodianilidate was used as the starting nucleotide block. Condensation of protected CCCCGCp or successive condensations of protected CCCp and CGCp gave the protected undecamer in satisfactory yields. The final condensation of the undecamer to protected UCCGGCp yielded the protected heptadecamer, and the product was deprotected to give the 3'-phosphorylated heptadecanucleotide UCCGGCCCCCGAACCAp. A hexadecanucleotide corresponding to the 3'-end of the same tRNAMetf was also synthesized by the phosphotriester method by condensation of the undecamer with protected CCGGCp. The hexadecamer was deblocked and purified by chromatography on ion-exchange and reverse phase supports. This deprotected hexadecanucleotide CCGGCCCCCGCAACCAp (corresponding to bases 62-77) can be joined to the previously synthesized heptamer corresponding to the eukaryotic loop VI sequences to construct a hybrid tRNA.
    DOI:
    10.1248/cpb.29.2799
点击查看最新优质反应信息

同类化合物

腺苷-3’-磷酸 胸苷酰-(3'-5')-胸苷氰基乙基磷酰三酯 胸腺嘧啶脱氧核苷3-单磷酸铵盐水合物 胞啶-3'-单磷酸二钠盐 环(腺苷酰(3'-5')尿苷单磷酸酯) 尿苷酸 尿苷溴乙酰甲醇5'-二磷酸酯 尿苷氯乙酰甲醇5'-二磷酸酯 丁二酸,甲基-,1-(苯基甲基)酯,(2R)-(9CI) [(2R,3S,4R,5R)-5-(6-氨基嘌呤-9-基)-4-羟基-2-(羟基甲基)四氢呋喃-3-基]苯基磷酸氢酯 [(2R,3S,4R,5R)-5-(2-氨基-6-氧代-3H-嘌呤-9-基)-2-[(2-甲酰基苯氧基)甲基]-4-羟基四氢呋喃-3-基]磷酸二氢酯 N-苯甲酰基-2'-脱氧-3'-胞苷酸2-氯苯基2-氰基乙基酯 8-[(E)-苄亚基氨基]-2'-脱氧腺苷3'-(磷酸二氢酯) 5-甲基-2'-脱氧胞苷-3'-磷酸 3'-(二氢磷酸)鸟嘌呤核苷 3'-(1-丁基磷酰)腺苷 2ˊ-脱氧胞苷-3ˊ-一磷酸 2-脱氧腺苷-3-单磷酸酯*铵 2'-脱氧鸟苷 3'-(磷酸二氢酯) 2'-脱氧腺苷酰-(3'-5')-2'-脱氧腺苷酰-(3'-5)-2'-脱氧腺苷 2'-脱氧-3'-胞苷酸二钠盐 2' -脱氧3' -磷酸游离酸 [3']thymidylic acid mono-[4-(2-iodo-acetylamino)-phenyl] ester 5-Fluor-1-β-D-arabinofuranosylcytosin-3'-phosphat [3']thymidylic acid mono-[4-(2-bromo-acetylamino)-phenyl] ester O2'-Methylguanosin-3'-phosphorsaeure uridine-3'-(2-cyanoethyl)phosphate [3']thymidylic acid mono-[4-(2-chloro-acetylamino)-phenyl] ester (1R)-1-(6-amino-purin-9-yl)-O3-phosphono-1,5-anhydro-D-glucitol Thymidin-3'-(2,4-dinitrophenyl)phosphat N4-Dimethylamino-methylen-2',5'-bis-O-(1-ethoxy-ethyl)-cytidin-3'-phosphat (2R)-3-((hydroxy(((2R,3S,5R)-2-(hydroxymethyl)-5-(5-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)tetrahydrofuran-3-yl)oxy)phosphoryl)oxy)propane-1,2-diyl dioleate 3-Methyl-uridin-3'-phosphat 2'-O-(tert-butyldimethylsilyl)inosine 3'-(allyl 2-cyanoethylphosphate) 2'-O-(2-tetrahydrofuranyl)-N4-(4-anisoyl)cytidine-3'-(2-chlorophenoxy)phosphoryl-2'-O-(2-tetrahydrofuranyl)-N4-(4-anisoyl)cytidine-3'-(2-chlorophenoxy)phosphoryl-2'-O-(2-tetrahydrofuranyl)-N4-(4-anisoyl)cytidine-3'-(2-chlorophenoxy)phosphoryl-2'-O-(2-tetrahydrofuranyl)-N4-(4-anisoyl)cytidine-3'-[O-(2-cyanoethyl)(2-chlorophenyl)phosphate] Phosphoric acid mono-[(2S,5R)-5-(2,4-diamino-pyrrolo[2,3-d]pyrimidin-7-yl)-2,5-dihydro-furan-2-ylmethyl] ester; compound with triethyl-amine 9-β.D-Glucopyranosyl-adenin-4'-phosphat 4-Oxo-pentanoic acid (2R,3S,5R)-3-[(2-chloro-phenoxy)-hydroxy-phosphoryloxy]-5-(5-methyl-2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-yl)-tetrahydro-furan-2-ylmethyl ester N(4),O(2')-Dibenzoyl-cytidin-3'-phosphat cis-((5-((4-amino-2-oxopyrimidin-1(2H)-yl)methyl)-1,3-oxathiolan-2-yl)methyl) (2R,3S,5R)-2-(hydroxymethyl)-5-(5-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)tetrahydrofuran-3-yl hydrogen phosphate 1,20-(icosanedioxy)bis-(3'-phosphatidyl-2'-deoxythymidine) 4-N-benzoyl-5'-O-[di(2-cyanoethyloxy)phosphoryl]-2'-deoxycytidylyl-{3'-OP-(2-cyanoethyl)->5'}-6-N-benzoyl-2',3'-di-O-(tert-butyldimethylsilyl)adenosine [3']uridylic acid mono-[1-(5,6-bis-ethoxycarbonylamino-pyrimidin-4-ylamino)-β-D-1-deoxy-ribofuranos-5-yl] ester 1-β-D-Arabinofuranosylcytidin-3'-phosphat OH[AA]AZMB